Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects.

Curr Treat Options Gastroenterol · 2020 · PMC7680210 · PMID 33250629

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

No differences were seen between groups in the rate of clinical remission; a per-protocol analysis of the total and partial Mayo scores favored CBD while secondary outcomes such as quality of life showed a trend to improvement in patients given the CBD extract.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.